INmune Bio, Inc.
NASDAQ:INMB
5.19 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0.014 | 0.028 | 0.043 | 0.046 | 0.038 | 0.097 | 0.098 | 0.016 | 0.163 | 0.163 | 0.014 | 0 | 0.004 | 0.011 | 0 | 0 | 0 | 77.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0.014 | 0.028 | 0.043 | 0.046 | 0.038 | 0.097 | 0.098 | 0.016 | 0.163 | 0.163 | 0.014 | 0 | 0.004 | 0.011 | 0 | 0 | 0 | 77.688 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 7.053 | 8.693 | 6.007 | 5.985 | 4.148 | 4.133 | 3.41 | 5.159 | 4.189 | 4.309 | 7.068 | 6.52 | 4.464 | 2.491 | 1.859 | 2.363 | 0.903 | 0.793 | 0.867 | 1.168 | 0.294 | 0.102 | 0.515 | 0.199 | 0.287 | 0.104 | 0.268 | 0.046 | 0.065 | 0.058 | 0.028 | 0.028 |
| General & Administrative Expenses
| 2.812 | 2.338 | 2.4 | 2.586 | 2.309 | 2.328 | 2.329 | 2.382 | 2.215 | 2.332 | 2.125 | 2.515 | 2.09 | 2.061 | 1.361 | 2.456 | 1.204 | 1.299 | 1.466 | 1.916 | 1.677 | 1.809 | 1.365 | 1.341 | 5.887 | 2.742 | 0.16 | 0.261 | 0.1 | 0.062 | 0.057 | 0.027 |
| Selling & Marketing Expenses
| 0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.812 | 2.338 | 2.4 | 2.586 | 2.309 | 2.328 | 2.329 | 2.382 | 2.215 | 2.332 | 2.125 | 2.515 | 2.09 | 2.061 | 1.361 | 2.456 | 1.204 | 1.299 | 1.466 | 1.916 | 1.677 | 1.809 | 1.365 | 1.341 | 5.887 | 2.742 | 0.16 | 0.261 | 0.1 | 0.062 | 0.057 | 0.027 |
| Other Expenses
| 0.119 | -0.008 | -0.029 | -0.035 | -0.09 | -0.113 | -0.191 | -0.282 | -0.45 | -0.425 | -0.641 | -0.437 | -0.101 | -0.008 | 0.005 | 0.102 | -0 | 0.022 | 0 | 0.017 | 0.036 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 9.865 | 11.031 | 8.407 | 8.571 | 6.457 | 6.461 | 5.739 | 7.541 | 6.404 | 6.641 | 9.193 | 9.035 | 6.554 | 4.552 | 3.22 | 4.819 | 2.107 | 2.092 | 2.332 | 3.084 | 1.97 | 1.911 | 1.88 | 1.54 | 6.174 | 2.846 | 0.428 | 0.308 | 0.165 | 0.031 | 0.135 | 0.054 |
| Operating Income
| -9.865 | -11.017 | -8.379 | -8.528 | -6.411 | -6.423 | -5.642 | -7.443 | -6.388 | -6.478 | -9.03 | -9.021 | -6.554 | -4.548 | -3.209 | -4.819 | -2.107 | -2.092 | -2.332 | -3.084 | -0.428 | -1.911 | -1.88 | -1.54 | -6.174 | -2.846 | -0.428 | -0.308 | -0.165 | -0.119 | -0.085 | -0.054 |
| Operating Income Ratio
| 0 | -786.929 | -299.25 | -198.326 | -139.37 | -169.026 | -58.165 | -75.949 | -399.25 | -39.742 | -55.399 | -644.357 | 0 | -1,137 | -293.959 | 0 | 0 | 0 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.119 | -0.008 | -0.029 | -0.035 | -0.09 | -0.113 | -0.191 | -0.282 | -0.45 | -0.425 | -0.641 | -0.437 | -0.101 | -0.008 | 0.005 | 0.102 | -0 | 0.022 | 0.014 | 0.017 | 1.542 | 0.01 | -12,440.023 | 0 | 0 | 0 | -0 | 0 | 0 | 0.15 | -0.05 | 0 |
| Income Before Tax
| -9.746 | -11.025 | -8.408 | -8.563 | -6.501 | -6.536 | -5.833 | -7.725 | -6.838 | -6.903 | -9.671 | -9.458 | -6.655 | -4.556 | -3.204 | -4.717 | -2.108 | -2.07 | -2.318 | -3.067 | -0.392 | -1.901 | -1.88 | -1.54 | -6.174 | -2.846 | -0.428 | -0.308 | -0.165 | 0.031 | -0.135 | -0.054 |
| Income Before Tax Ratio
| 0 | -787.5 | -300.286 | -199.14 | -141.326 | -172 | -60.134 | -78.827 | -427.375 | -42.35 | -59.331 | -675.571 | 0 | -1,139 | -293.54 | 0 | 0 | 0 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -9.865 | -11.017 | 14.826 | -8.528 | -6.411 | 0.113 | 0.191 | 0.282 | 0.45 | 0.425 | 21.31 | -9.021 | -6.554 | -4.548 | -3.209 | -4.82 | -2.107 | -2.092 | -2.332 | -3.084 | 1.506 | -1.911 | -12,441.903 | -1.54 | -6.174 | -2.846 | -0.428 | -0.308 | 0 | 0.15 | -0.05 | 0 |
| Net Income
| -9.746 | -11.025 | -8.408 | -8.563 | -6.501 | -6.649 | -6.024 | -8.007 | -7.288 | -7.328 | -9.671 | -9.458 | -6.655 | -4.556 | -3.204 | -4.717 | -2.108 | -2.07 | -2.318 | -3.067 | -0.392 | -1.901 | -1.88 | -1.54 | -6.174 | -2.846 | -0.428 | -0.308 | -0.165 | 0.031 | -0.135 | -0.054 |
| Net Income Ratio
| 0 | -787.5 | -300.286 | -199.14 | -141.326 | -174.974 | -62.103 | -81.704 | -455.5 | -44.957 | -59.331 | -675.571 | 0 | -1,139 | -293.54 | 0 | 0 | 0 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.5 | -0.61 | -0.47 | -0.48 | -0.36 | -0.37 | -0.34 | -0.45 | -0.41 | -0.41 | -0.56 | -0.55 | -0.44 | -0.32 | -0.25 | -0.36 | -0.2 | -0.19 | -0.22 | -0.28 | -0.039 | -0.2 | -0.17 | -0.14 | -0.55 | -0.25 | -0.038 | -0.027 | -0.028 | 0.006 | -0.027 | -0.011 |
| EPS Diluted
| -0.5 | -0.61 | -0.47 | -0.48 | -0.36 | -0.37 | -0.34 | -0.45 | -0.41 | -0.41 | -0.56 | -0.55 | -0.44 | -0.32 | -0.25 | -0.36 | -0.2 | -0.19 | -0.22 | -0.28 | -0.039 | -0.2 | -0.17 | -0.14 | -0.55 | -0.25 | -0.038 | -0.027 | -0.028 | 0.006 | -0.027 | -0.011 |
| EBITDA
| -9.865 | -11.017 | -8.379 | -8.528 | -6.411 | -6.423 | -5.642 | -7.443 | -6.388 | -6.478 | -9.03 | -9.021 | -6.554 | -4.548 | -3.209 | -4.819 | -2.107 | -2.092 | -2.332 | -3.084 | -3.512 | -1.911 | -1.88 | -1.54 | -6.174 | -2.846 | -0.428 | -0.308 | 0 | 0.15 | -0.05 | 0 |
| EBITDA Ratio
| 0 | -786.929 | -299.25 | -198.326 | -139.37 | -169.026 | -58.165 | -75.949 | -399.25 | -39.742 | -55.399 | -644.357 | 0 | -1,137 | -293.959 | 0 | 0 | 0 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |